Trial Profile
Evaluation to the effects on the tear film lipid layer of 3% Diquafosol Sodium ophthalmic solution for Dry Eye patients with Meibomian gland dysfunction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Mar 2018
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 16 Mar 2018 Status changed from recruiting to completed.
- 28 Sep 2016 New trial record